- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Champix ( Varenicline )
Champix (Varenicline) is a smoking cessation aid specifically developed to help motivated adults stop smoking. It works as a partial agonist at alpha‑4 beta‑2 nicotinic acetylcholine receptors in the brain, where it both stimulates these receptors (reducing nicotine craving and withdrawal symptoms) and blocks nicotine from binding to them (diminishing the rewarding and reinforcing effects of smoking). Champix is most effective when used in combination with supportive counselling and a structured quit program.
Usual adult dose: The recommended dosing begins with a 1‑week titration: Days 1‑3: 0.5 mg once daily; Days 4‑7: 0.5 mg twice daily; Day 8 to end of treatment: 1 mg twice daily. The patient should set a date to stop smoking, and Champix dosing should usually start 1‑2 weeks before this date. Treatment is typically continued for 12 weeks; for patients who successfully quit, an additional 12‑week course (1 mg twice daily) may be considered for maintenance of abstinence. A gradual quit approach (reducing smoking over 12 weeks, then quitting) is an alternative for patients unable or unwilling to quit abruptly.
Dosage form: Film‑coated tablets: 0.5 mg (white, capsular‑shaped) and 1 mg (light blue, capsular‑shaped). Available as an Initiation Pack (containing both strengths for dose titration) and a Continuation Pack (1 mg tablets).
Onset of action: Steady‑state plasma concentrations are reached within 4 days of repeat dosing. Craving and withdrawal symptom reduction may begin during the first week of treatment; maximal therapeutic effect is typically achieved after several weeks of abstinence‑focused therapy.
Duration of action: Approximately 24 hours, permitting twice‑daily maintenance dosing. The elimination half‑life is approximately 24 hours.
Alcohol recommendation: Alcohol consumption should be avoided during treatment with Champix. Drinking alcohol may increase the risk of developing neuropsychiatric symptoms, including agitation, aggression, and depressed mood. Patients should limit alcohol intake until they know how Champix affects them.
Most common side effects: Nausea, vomiting, abnormal dreams, insomnia, headache, constipation, and flatulence. Nausea is the most frequently reported adverse effect, occurring in approximately 30% of patients; it is usually mild to moderate and diminishes over time.
Would you like to try Champix (Varenicline) without a prescription?
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
